157 related articles for article (PubMed ID: 16433680)
41. Potential role of CCL27 and CCR10 expression in melanoma progression and immune escape.
Simonetti O; Goteri G; Lucarini G; Filosa A; Pieramici T; Rubini C; Biagini G; Offidani A
Eur J Cancer; 2006 May; 42(8):1181-7. PubMed ID: 16644201
[TBL] [Abstract][Full Text] [Related]
42. CCR10 and CCL27 are overexpressed in cutaneous squamous cell carcinoma.
Kai H; Kadono T; Kakinuma T; Tomita M; Ohmatsu H; Asano Y; Tada Y; Sugaya M; Sato S
Pathol Res Pract; 2011 Jan; 207(1):43-8. PubMed ID: 21144674
[TBL] [Abstract][Full Text] [Related]
43. A possible role for CCL27/CTACK-CCR10 interaction in recruiting CD4 T cells to skin in human graft-versus-host disease.
Faaij CM; Lankester AC; Spierings E; Hoogeboom M; Bowman EP; Bierings M; Révész T; Egeler RM; van Tol MJ; Annels NE
Br J Haematol; 2006 Jun; 133(5):538-49. PubMed ID: 16681643
[TBL] [Abstract][Full Text] [Related]
44. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin.
Vestergaard C; Bang K; Gesser B; Yoneyama H; Matsushima K; Larsen CG
J Invest Dermatol; 2000 Oct; 115(4):640-6. PubMed ID: 10998136
[TBL] [Abstract][Full Text] [Related]
45. Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes.
Kanda N; Watanabe S
Endocrinology; 2007 May; 148(5):2317-25. PubMed ID: 17255201
[TBL] [Abstract][Full Text] [Related]
46. CCL27-transgenic mice show enhanced contact hypersensitivity to Th2, but not Th1 stimuli.
Kagami S; Saeki H; Tsunemi Y; Nakamura K; Kuwano Y; Komine M; Nakayama T; Yoshie O; Tamaki K
Eur J Immunol; 2008 Mar; 38(3):647-57. PubMed ID: 18266301
[TBL] [Abstract][Full Text] [Related]
47. Augmentation of CCL17 and CCL28 gene expression by TNF-alpha, IL-1beta, or IFN-gamma in cultured canine keratinocytes.
Shibata S; Maeda S; Maeda S; Chimura N; Kondo N; Fukata T
Res Vet Sci; 2010 Jun; 88(3):422-6. PubMed ID: 20022349
[TBL] [Abstract][Full Text] [Related]
48. Involvement of CCL27-CCR10 interactions in drug-induced cutaneous reactions.
Tapia B; Padial A; Sánchez-Sabaté E; Alvarez-Ferreira J; Morel E; Blanca M; Bellón T
J Allergy Clin Immunol; 2004 Aug; 114(2):335-40. PubMed ID: 15316512
[TBL] [Abstract][Full Text] [Related]
49. CCL27 Signaling in the Tumor Microenvironment.
Martínez-Rodríguez M; Monteagudo C
Adv Exp Med Biol; 2021; 1302():113-132. PubMed ID: 34286445
[TBL] [Abstract][Full Text] [Related]
50. Potential inhibitory effects of the traditional herbal prescription Hyangso-san against skin inflammation via inhibition of chemokine production and inactivation of STAT1 in HaCaT keratinocytes.
Lim HS; Yo SR; Lee MY; Seo CS; Shin HK; Jeong SJ
Mol Med Rep; 2018 Feb; 17(2):2515-2522. PubMed ID: 29207093
[TBL] [Abstract][Full Text] [Related]
51. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines.
Giustizieri ML; Mascia F; Frezzolini A; De Pità O; Chinni LM; Giannetti A; Girolomoni G; Pastore S
J Allergy Clin Immunol; 2001 May; 107(5):871-7. PubMed ID: 11344355
[TBL] [Abstract][Full Text] [Related]
52. Temporal production of CCL28 corresponds to eosinophil accumulation and airway hyperreactivity in allergic airway inflammation.
John AE; Thomas MS; Berlin AA; Lukacs NW
Am J Pathol; 2005 Feb; 166(2):345-53. PubMed ID: 15681819
[TBL] [Abstract][Full Text] [Related]
53. Kinetics and differential expression of the skin-related chemokines CCL27 and CCL17 in psoriasis, atopic dermatitis and allergic contact dermatitis.
Riis JL; Johansen C; Vestergaard C; Bech R; Kragballe K; Iversen L
Exp Dermatol; 2011 Oct; 20(10):789-94. PubMed ID: 21707761
[TBL] [Abstract][Full Text] [Related]
54. NF-kappa B-inducing kinase is a common mediator of IL-17-, TNF-alpha-, and IL-1 beta-induced chemokine promoter activation in intestinal epithelial cells.
Awane M; Andres PG; Li DJ; Reinecker HC
J Immunol; 1999 May; 162(9):5337-44. PubMed ID: 10228009
[TBL] [Abstract][Full Text] [Related]
55. Interleukin-1 regulates keratinocyte expression of T cell targeting chemokines through interleukin-1 receptor associated kinase-1 (IRAK1) dependent and independent pathways.
Sanmiguel JC; Olaru F; Li J; Mohr E; Jensen LE
Cell Signal; 2009 May; 21(5):685-94. PubMed ID: 19166933
[TBL] [Abstract][Full Text] [Related]
56. Expression of CCL28 by Reed-Sternberg cells defines a major subtype of classical Hodgkin's disease with frequent infiltration of eosinophils and/or plasma cells.
Hanamoto H; Nakayama T; Miyazato H; Takegawa S; Hieshima K; Tatsumi Y; Kanamaru A; Yoshie O
Am J Pathol; 2004 Mar; 164(3):997-1006. PubMed ID: 14982853
[TBL] [Abstract][Full Text] [Related]
57. DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27.
Sigmundsdottir H; Pan J; Debes GF; Alt C; Habtezion A; Soler D; Butcher EC
Nat Immunol; 2007 Mar; 8(3):285-93. PubMed ID: 17259988
[TBL] [Abstract][Full Text] [Related]
58. Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris.
Kakinuma T; Saeki H; Tsunemi Y; Fujita H; Asano N; Mitsui H; Tada Y; Wakugawa M; Watanabe T; Torii H; Komine M; Asahina A; Nakamura K; Tamaki K
J Allergy Clin Immunol; 2003 Mar; 111(3):592-7. PubMed ID: 12642842
[TBL] [Abstract][Full Text] [Related]
59. Lipoxin A4 inhibits proliferation and inflammatory cytokine/chemokine production of human epidermal keratinocytes associated with the ERK1/2 and NF-κB pathways.
Hu F; Liu XX; Wang X; Alashkar M; Zhang S; Xu JT; Zhong XL; He MW; Feng AP; Chen HX
J Dermatol Sci; 2015 Jun; 78(3):181-8. PubMed ID: 25847211
[TBL] [Abstract][Full Text] [Related]
60. Identification of the signaling pathway of TNF-α-induced CCL17/TARC transcription in a canine keratinocyte cell line.
Shibata S; Maeda S; Kondo N; Chimura N; Inoue A; Fukata T
Vet Immunol Immunopathol; 2011 Feb; 139(2-4):90-8. PubMed ID: 20837364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
